242 related articles for article (PubMed ID: 20546955)
21. HMGB1 in Systemic Lupus Erythematosus.
Liu T; Son M; Diamond B
Front Immunol; 2020; 11():1057. PubMed ID: 32536928
[TBL] [Abstract][Full Text] [Related]
22. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.
Muth IE; Zschüntzsch J; Kleinschnitz K; Wrede A; Gerhardt E; Balcarek P; Schreiber-Katz O; Zierz S; Dalakas MC; Voll RE; Schmidt J
Exp Neurol; 2015 Sep; 271():189-97. PubMed ID: 26048613
[TBL] [Abstract][Full Text] [Related]
23. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
[TBL] [Abstract][Full Text] [Related]
24. High-mobility group box-1 in sterile inflammation.
Tsung A; Tohme S; Billiar TR
J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
[TBL] [Abstract][Full Text] [Related]
25. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Nomoto M; Miyashita S; Suzuki K; Nakamura M; Watanabe K
Exp Dermatol; 2015 Jun; 24(6):418-23. PubMed ID: 25739980
[TBL] [Abstract][Full Text] [Related]
26. The Immune Tolerance Role of the HMGB1-RAGE Axis.
Watanabe H; Son M
Cells; 2021 Mar; 10(3):. PubMed ID: 33807604
[TBL] [Abstract][Full Text] [Related]
27. Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells.
Dhumale SS; Waghela BN; Pathak C
IUBMB Life; 2015 May; 67(5):361-73. PubMed ID: 25983116
[TBL] [Abstract][Full Text] [Related]
28. Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer.
Ohmori H; Luo Y; Kuniyasu H
Expert Opin Ther Targets; 2011 Feb; 15(2):183-93. PubMed ID: 21204727
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue.
Casula M; Iyer AM; Spliet WG; Anink JJ; Steentjes K; Sta M; Troost D; Aronica E
Neuroscience; 2011 Apr; 179():233-43. PubMed ID: 21303685
[TBL] [Abstract][Full Text] [Related]
30. High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.
Chirico V; Lacquaniti A; Salpietro V; Munafò C; Calabrò MP; Buemi M; Arrigo T; Salpietro C
Eur J Pediatr; 2014 Sep; 173(9):1123-36. PubMed ID: 24809802
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus.
Baroni Pietto MC; Glembotsky AC; Lev PR; Marín Oyarzún CR; De Luca G; Gomez G; Collado MV; Charó N; Cellucci AS; Heller PG; Goette NP; Marta RF
Immunobiology; 2024 Jan; 229(1):152782. PubMed ID: 38159527
[TBL] [Abstract][Full Text] [Related]
32. High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps.
Dzaman K; Zagor M; Molinska-Glura M; Krzeski A
Folia Histochem Cytobiol; 2015; 53(1):70-8. PubMed ID: 25772690
[TBL] [Abstract][Full Text] [Related]
33. The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation.
Wan W; Cao L; Khanabdali R; Kalionis B; Tai X; Xia S
J Immunol Res; 2016; 2016():6430423. PubMed ID: 27294160
[TBL] [Abstract][Full Text] [Related]
34. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
35. Systemic lupus erythematosus: a matter of life and death.
Pisetsky DS; Rönnblom L
Arthritis Rheum; 2009 Jun; 60(6):1567-70. PubMed ID: 19479835
[No Abstract] [Full Text] [Related]
36. A possible role of HMGB1 in DNA demethylation in CD4+ T cells from patients with systemic lupus erythematosus.
Li Y; Huang C; Zhao M; Liang G; Xiao R; Yung S; Chan TM; Lu Q
Clin Dev Immunol; 2013; 2013():206298. PubMed ID: 24082908
[TBL] [Abstract][Full Text] [Related]
37. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells.
Wild CA; Bergmann C; Fritz G; Schuler P; Hoffmann TK; Lotfi R; Westendorf A; Brandau S; Lang S
Int Immunol; 2012 Aug; 24(8):485-94. PubMed ID: 22473704
[TBL] [Abstract][Full Text] [Related]
38. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage.
Li D; Lei C; Zhang S; Zhang S; Liu M; Wu B
Neurosci Lett; 2015 Nov; 609():109-19. PubMed ID: 26483322
[TBL] [Abstract][Full Text] [Related]
39. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.
Zurolo E; Iyer A; Maroso M; Carbonell C; Anink JJ; Ravizza T; Fluiter K; Spliet WG; van Rijen PC; Vezzani A; Aronica E
Brain; 2011 Apr; 134(Pt 4):1015-32. PubMed ID: 21414994
[TBL] [Abstract][Full Text] [Related]
40. The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens.
Willis WL; Wang L; Wada TT; Gardner M; Abdouni O; Hampton J; Valiente G; Young N; Ardoin S; Agarwal S; Freitas MA; Wu LC; Jarjour WN
J Biol Chem; 2018 Jun; 293(22):8394-8409. PubMed ID: 29618516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]